Clinical Research Details

Descriptive Information
Longitudinal assessment of clinical disability, cognition, quality of life, fatigue, brain magnetic resonance imaging measures, and optical coherence tomography findings in multiple sclerosis patients treated with AUBAGIO (teriflunomide)

Bassem Yamout
yamoutba@gmail.com

TERIFR07918
Completed

Observational  


No
Collaborators
  • Samia Khoury
  • Lina Abdul-Latif Malaeb
  • Ingrid Corbani
  • Ribal Haddad
  • Rami Fakih
  • Nabil El Ayoubi
  • Marianne Said
  • Joelle Massouh
Sponsors
  • Genzyme
Conditions and Keywords
Multiple Sclerosis
Multiple Sclerosis,Teriflunomide
Study Design
Prospective
Cohort
Eligibility and IRB
Both
Min:
Max:
Yes
No